Work

A phase II trial of cetuximab as therapy for recurrent non-small cell lung cancer (NSCLC)

Year: 2004

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2004.22.14_suppl.7084

Authors: T. J. Lynch, R. Lilenbaum, P. Bonomi, R. Ansari, R. Govindan, P. A. Janne, N. Hanna

Institutions: Washington University in St. Louis, Massachusetts General Hospital, Dana-Farber Cancer Institute, Rush University

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2343670117

Cites:

Cited by: 44

Related to: 10